HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Systemic administration of FC-77 dampens ischemia-reperfusion-induced acute lung injury in rats.

Abstract
Systemic administration of perfluorocarbons (PFCs) reportedly attenuates acute lung injury induced by acid aspiration and phorbol myristate acetate. However, the effects of PFCs on ischemia-reperfusion (IR)-induced lung injury have not been investigated. Typical acute lung injury was induced in rats by 60 min of ischemia and 60 min of reperfusion in isolated and perfused rat lung model. Rat lungs were randomly assigned to receive PBS (control), 1 % FC-77, IR only, or IR with different doses of FC-77 (0.1 %, 0.5 %, or 1 %). Subsequently, bronchoalveolar lavage fluid (BALF), perfusate, and lung tissues were collected to evaluate the degree of lung injury. IR caused a significant increase in the following parameters: pulmonary arterial pressure, capillary filtration coefficient, lung weight gain, lung weight/body weight ratio, wet/dry lung weight ratio, and protein concentration in BALF. TNF-α and cytokine-induced neutrophil chemoattractant-1 concentrations in perfusate samples and MDA concentration and MPO activities in lung tissues were also significantly increased. Histopathology showed increased septal thickness and neutrophil infiltration in the lung tissues. Furthermore, NF-κB activity was significantly increased in the lungs. However, pretreatment with 1 % FC-77 prior to IR significantly attenuated the increases in these parameters. In conclusion, our results suggest that systemic FC-77 administration had a protective effect on IR-induced acute lung injury. These protective mechanisms may have been mediated by the inhibition of NF-κB activation and attenuation of subsequent inflammatory response.
AuthorsShi-Jye Chu, Kun-Lun Huang, Shu-Yu Wu, Fu-Chang Ko, Geng-Chin Wu, Rui-Ying Li, Min-Hui Li
JournalInflammation (Inflammation) Vol. 36 Issue 6 Pg. 1383-92 (Dec 2013) ISSN: 1573-2576 [Electronic] United States
PMID23807052 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chemokine CXCL1
  • Cxcl1 protein, rat
  • Fluorocarbons
  • Rela protein, rat
  • Transcription Factor RelA
  • Tumor Necrosis Factor-alpha
  • fluorocarbon 77
Topics
  • Acute Lung Injury (drug therapy)
  • Animals
  • Bronchoalveolar Lavage Fluid
  • Chemokine CXCL1 (metabolism)
  • Disease Models, Animal
  • Fluorocarbons (therapeutic use)
  • Lung (drug effects)
  • Male
  • Neutrophil Infiltration (drug effects)
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury (drug therapy)
  • Transcription Factor RelA (metabolism)
  • Tumor Necrosis Factor-alpha (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: